Accretive Health (ACHI) 5.3050 $ACHI
Jacobs Misses Q2 Earnings and Revenues; Gives Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 28, 10:40AM CDT
Jacobs Engineering Group Inc. (JEC) reported weak results for fiscal second-quarter 2015 (ended Mar 27, 2015).
JEC: 43.77 (-0.23), ADI: 63.32 (+0.15), ACTA: 13.34 (+0.05)
Tetra Tech Shares Up 1% on $35M Environmental Contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 3:10PM CDT
Shares of premium technical service providing company Tetra Tech Inc. (TTEK) gained 1% following the recently secured $35 million contract from the Department of the Environment in the District of Columbia (D.C.).
TTEK: 26.18 (-0.07), SMED: 5.68 (-0.05), LDR: 31.18 (+0.18)
Healthcare Services Misses on Q1 Earnings, Ups Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 8:10AM CDT
Healthcare Services Group, Inc. (HCSG) reported net income of 22 cents per share in the first quarter of 2015, missing the Zacks Consensus Estimate by a penny.
EXAM: 40.29 (+0.39), HURN: 62.62 (-0.08), HCSG: 30.38 (-0.13)
Monsanto Upgraded to Hold on Innovations & Market Tailwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:50PM CDT
On Apr 14, 2015, Zacks Investment Research upgraded Monsanto Company (MON) to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell) primarily on account of its business innovations and strong growth initiatives.
MON: 120.60 (-0.22), AKG: 1.68 (+0.01)
KBR to Boost Gulf Coast Construction Trade on Flint Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 12:20PM CDT
Premium technical service company KBR, Inc. (KBR) recently secured a reimbursable contract from Flint Hills Resources.
KBR: 18.15 (-0.03), BAH: 28.31 (-0.02), CRAI: 29.14 (-0.29)
Applied Industrial Secures 3rd Consecutive 5-Year GSA Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 10:30AM CDT
Applied Industrial Technologies, Inc. (AIT) lately reinforced its government contract base by securing the third consecutive renewal of a five-year deal with Government Services Administration ("GSA"
.
BAH: 28.31 (-0.02), AIT: 42.45 (-0.21), ROLL: 73.08 (+0.32)
Jacobs (JEC) Downgraded to Sell on Weak Business Milieu - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 12:10PM CDT
On Apr 1, 2015, Zacks Investment Research downgraded Jacobs Engineering Group Inc. (JEC) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold) primarily due to an unfavorable business environment.
JEC: 43.77 (-0.23), BR: 52.88 (+0.13), BAH: 28.31 (-0.02)
Accretive Health President & CEO to Serve as Panelist
Business Wire - Mon Mar 09, 2:32PM CDT
Accretive Health, Inc., is proud to announce that its President and Chief Executive Officer, Emad Rizk, M.D., is slated as a featured panelist at the 12th World Health Care Congress in Washington, D.C., March 22-25, 2015. Dr. Rizk will be speaking on "Align Strategies and Integrate Systems to Succeed in a Blended Payment Environment" on Tuesday, March 24. Joining him on the esteemed panel will be Earl Steinberg, M.D., chief executive officer of xG Health Solutions, Inc., in Columbia, Md., and executive vice president, innovation and dissemination, Geisinger Health System in Danville, Pa., and Diane Corrigan, corporate vice president of network development and system integration, at Penn Medicine in Philadelphia, Pa. Gabriel Imperato, president of the Health Care Compliance Association, will moderate the panel discussion.
Accretive Health President to Keynote Wharton Health Care Business Conference
Business Wire - Wed Feb 18, 12:04PM CST
Accretive Health President and Chief Executive Officer Emad Rizk, M.D., will keynote the 21st Annual Wharton Health Care Business Conference held Feb. 19-20, 2015. The conference, "Disruption Amidst Uncertainty - Adapting and Innovating for the Future," will be held at The Union League of Philadelphia.
Accretive Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 05, 4:50PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced its management team will present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15th 2015 at 9:00 am PST in San Francisco, where management will discuss the Company's operations and business.
JPM: 66.22 (+0.34)
Accretive Health Completes Financial Restatement and Provides Business Update
Business Wire - Tue Dec 30, 3:00PM CST
--Timing of revenue recognition places emphasis on cash generated from customer contracts; company introduces new non-GAAP measures
Accretive Health - Pending Restatement Offers A 1:4 Risk/Reward With A Near-Term Catalyst
Sententia Capital - Seeking Alpha - Wed Dec 24, 5:00AM CST
Accretive Health - Long Sententia Capital Management December 2014 Ticker: OTCPK:ACHI Mkt cap: $786m Price: $8.60 Intrinsic value: $11 Recommendation : Accretive Health is a buy at $8 with a base case of $11, representing 35%...
Accretive Health Provides Updated Timeline for Completion of Restatement
Business Wire - Fri Dec 19, 6:35PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it is in the final stages of completing its financial restatement. The Company currently expects to file its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission (SEC) after the market closes on December 30, 2014. The 2013 Form 10-K will include results for the fiscal years ended December 31, 2013 and December 31, 2012, and restated results for the fiscal year ended December 31, 2011. The company previously announced on November 12, 2014 that it expected to complete its restatement and related audits, and to file the 2013 Form 10-K by the middle of December.
AxelaCare Appoints Daniel C. Buning Chief Operating Officer
Business Wire - Tue Dec 16, 9:00AM CST
AxelaCare, a leading U.S. home intravenous therapy provider, announced today that Daniel C. Buning was appointed to serve as the company's chief operating officer.
MedAssets, Procured Health Tie Up for Value Analysis Models - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:50PM CST
MedAssets, Inc. (MDAS) recently announced a partnership with Procured Health to deliver a comprehensive approach for implementing better clinical value analysis programs.
MDAS: 20.51 (+0.18), PINC: 38.00 (-0.07), ATHN: 120.24 (+0.15)
Accretive Health: Completion Of The Restatement Is 3 Weeks Away - Buy Before Others Notice
Out of Favor Investing - Seeking Alpha - Sat Nov 15, 10:39AM CST
The Accretive Health (OTCPK: ACHI ) story is lengthy. To summarize, ACHI performs revenue cycle management (RCM) services for hospitals. A few years ago an employee lost a laptop in Minnesota and as a result Accretive lost a customer, was forced to...
Accretive Health Reports Inducement Grant
Business Wire - Wed Nov 12, 4:00PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in connection with the appointment of David Mason as the company's chief strategy officer, on November 11, 2014, Accretive Health granted to Mason a nonstatutory stock option and shares of restricted common stock (collectively the "Inducement Grants" as an inducement material to Mason's acceptance of employment with the company.
Accretive Health Names David Mason as Chief Strategy Officer
Business Wire - Tue Nov 11, 7:03AM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed David Mason as chief strategy officer, effective today.
Blue Cross Blue Shield of Arizona Advantage Adds Executive Leadership
PR Newswire - Mon Aug 11, 4:55PM CDT
Blue Cross® Blue Shield® of Arizona Advantage (BCBSAZ Advantage), an affiliate of Blue Cross Blue Shield of Arizona (BCBSAZ), has named Dave Firdaus as Chief Executive Officer. BCBSAZ Advantage is a joint venture between Banner Health and BCBSAZ to sell Medicare products. Firdaus previously served as Senior Vice President of Population Health for Accretive Health, Inc.
Jacobs Misses Q2 Earnings and Revenues; Gives Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 28, 10:40AM CDT
Jacobs Engineering Group Inc. (JEC) reported weak results for fiscal second-quarter 2015 (ended Mar 27, 2015).
JEC: 43.77 (-0.23), ADI: 63.32 (+0.15), ACTA: 13.34 (+0.05)
Tetra Tech Shares Up 1% on $35M Environmental Contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 3:10PM CDT
Shares of premium technical service providing company Tetra Tech Inc. (TTEK) gained 1% following the recently secured $35 million contract from the Department of the Environment in the District of Columbia (D.C.).
TTEK: 26.18 (-0.07), SMED: 5.68 (-0.05), LDR: 31.18 (+0.18)
Healthcare Services Misses on Q1 Earnings, Ups Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 8:10AM CDT
Healthcare Services Group, Inc. (HCSG) reported net income of 22 cents per share in the first quarter of 2015, missing the Zacks Consensus Estimate by a penny.
EXAM: 40.29 (+0.39), HURN: 62.62 (-0.08), HCSG: 30.38 (-0.13)
Monsanto Upgraded to Hold on Innovations & Market Tailwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:50PM CDT
On Apr 14, 2015, Zacks Investment Research upgraded Monsanto Company (MON) to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell) primarily on account of its business innovations and strong growth initiatives.
MON: 120.60 (-0.22), AKG: 1.68 (+0.01)
KBR to Boost Gulf Coast Construction Trade on Flint Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 12:20PM CDT
Premium technical service company KBR, Inc. (KBR) recently secured a reimbursable contract from Flint Hills Resources.
KBR: 18.15 (-0.03), BAH: 28.31 (-0.02), CRAI: 29.14 (-0.29)
Applied Industrial Secures 3rd Consecutive 5-Year GSA Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 10:30AM CDT
Applied Industrial Technologies, Inc. (AIT) lately reinforced its government contract base by securing the third consecutive renewal of a five-year deal with Government Services Administration ("GSA"
. BAH: 28.31 (-0.02), AIT: 42.45 (-0.21), ROLL: 73.08 (+0.32)
Jacobs (JEC) Downgraded to Sell on Weak Business Milieu - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 12:10PM CDT
On Apr 1, 2015, Zacks Investment Research downgraded Jacobs Engineering Group Inc. (JEC) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold) primarily due to an unfavorable business environment.
JEC: 43.77 (-0.23), BR: 52.88 (+0.13), BAH: 28.31 (-0.02)
Accretive Health President & CEO to Serve as Panelist
Business Wire - Mon Mar 09, 2:32PM CDT
Accretive Health, Inc., is proud to announce that its President and Chief Executive Officer, Emad Rizk, M.D., is slated as a featured panelist at the 12th World Health Care Congress in Washington, D.C., March 22-25, 2015. Dr. Rizk will be speaking on "Align Strategies and Integrate Systems to Succeed in a Blended Payment Environment" on Tuesday, March 24. Joining him on the esteemed panel will be Earl Steinberg, M.D., chief executive officer of xG Health Solutions, Inc., in Columbia, Md., and executive vice president, innovation and dissemination, Geisinger Health System in Danville, Pa., and Diane Corrigan, corporate vice president of network development and system integration, at Penn Medicine in Philadelphia, Pa. Gabriel Imperato, president of the Health Care Compliance Association, will moderate the panel discussion.
Accretive Health President to Keynote Wharton Health Care Business Conference
Business Wire - Wed Feb 18, 12:04PM CST
Accretive Health President and Chief Executive Officer Emad Rizk, M.D., will keynote the 21st Annual Wharton Health Care Business Conference held Feb. 19-20, 2015. The conference, "Disruption Amidst Uncertainty - Adapting and Innovating for the Future," will be held at The Union League of Philadelphia.
Accretive Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 05, 4:50PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced its management team will present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15th 2015 at 9:00 am PST in San Francisco, where management will discuss the Company's operations and business.
JPM: 66.22 (+0.34)
Accretive Health Completes Financial Restatement and Provides Business Update
Business Wire - Tue Dec 30, 3:00PM CST
--Timing of revenue recognition places emphasis on cash generated from customer contracts; company introduces new non-GAAP measures
Accretive Health - Pending Restatement Offers A 1:4 Risk/Reward With A Near-Term Catalyst
Sententia Capital - Seeking Alpha - Wed Dec 24, 5:00AM CST
Accretive Health - Long Sententia Capital Management December 2014 Ticker: OTCPK:ACHI Mkt cap: $786m Price: $8.60 Intrinsic value: $11 Recommendation : Accretive Health is a buy at $8 with a base case of $11, representing 35%...
Accretive Health Provides Updated Timeline for Completion of Restatement
Business Wire - Fri Dec 19, 6:35PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it is in the final stages of completing its financial restatement. The Company currently expects to file its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission (SEC) after the market closes on December 30, 2014. The 2013 Form 10-K will include results for the fiscal years ended December 31, 2013 and December 31, 2012, and restated results for the fiscal year ended December 31, 2011. The company previously announced on November 12, 2014 that it expected to complete its restatement and related audits, and to file the 2013 Form 10-K by the middle of December.
AxelaCare Appoints Daniel C. Buning Chief Operating Officer
Business Wire - Tue Dec 16, 9:00AM CST
AxelaCare, a leading U.S. home intravenous therapy provider, announced today that Daniel C. Buning was appointed to serve as the company's chief operating officer.
MedAssets, Procured Health Tie Up for Value Analysis Models - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:50PM CST
MedAssets, Inc. (MDAS) recently announced a partnership with Procured Health to deliver a comprehensive approach for implementing better clinical value analysis programs.
MDAS: 20.51 (+0.18), PINC: 38.00 (-0.07), ATHN: 120.24 (+0.15)
Accretive Health: Completion Of The Restatement Is 3 Weeks Away - Buy Before Others Notice
Out of Favor Investing - Seeking Alpha - Sat Nov 15, 10:39AM CST
The Accretive Health (OTCPK: ACHI ) story is lengthy. To summarize, ACHI performs revenue cycle management (RCM) services for hospitals. A few years ago an employee lost a laptop in Minnesota and as a result Accretive lost a customer, was forced to...
Accretive Health Reports Inducement Grant
Business Wire - Wed Nov 12, 4:00PM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in connection with the appointment of David Mason as the company's chief strategy officer, on November 11, 2014, Accretive Health granted to Mason a nonstatutory stock option and shares of restricted common stock (collectively the "Inducement Grants"
as an inducement material to Mason's acceptance of employment with the company. Accretive Health Names David Mason as Chief Strategy Officer
Business Wire - Tue Nov 11, 7:03AM CST
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed David Mason as chief strategy officer, effective today.
Blue Cross Blue Shield of Arizona Advantage Adds Executive Leadership
PR Newswire - Mon Aug 11, 4:55PM CDT
Blue Cross® Blue Shield® of Arizona Advantage (BCBSAZ Advantage), an affiliate of Blue Cross Blue Shield of Arizona (BCBSAZ), has named Dave Firdaus as Chief Executive Officer. BCBSAZ Advantage is a joint venture between Banner Health and BCBSAZ to sell Medicare products. Firdaus previously served as Senior Vice President of Population Health for Accretive Health, Inc.
